Preventing airborne infection with an intranasal cellulose powder formulation (Nasaleze Travel®)

Advances in Therapy

Volumn 24, Issue 5, 2007, Pages 1146-1153

  Hiltunen, Raimo ^a   Josling, Peter D ^b,d   James, Mike H ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Herbai Research Centre   (United Kingdom)

^c Nasaleze Limited   (United Kingdom)

^d Herbal Research Centre   (United Kingdom)

Author keywords

Nasaleze cellulose extract; Powdered garlic extract

Indexed keywords

CELLULOSE; GARLIC EXTRACT; NASALEZE; UNCLASSIFIED DRUG;

AIRBORNE INFECTION; ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG FORMULATION; DRUG TOLERABILITY; FINLAND; HUMAN; INFECTION CONTROL; MONOTHERAPY; OUTCOME ASSESSMENT; SYMPTOM; TREATMENT INDICATION; UNITED KINGDOM;

ADMINISTRATION, INTRANASAL; ADULT; AEROSOLS; CELLULOSE; GARLIC; HUMANS; PILOT PROJECTS; PLANT EXTRACTS; POWDERS; RESPIRATORY TRACT INFECTIONS; TRAVEL;

EID: 37249044725     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02877720     Document Type: Article

References (5)

1. Koch HP, Lawson LD. In: Garlic: The Science and Therapeutic Application of Allium sativum L. and Related Species. Baltimore: Williams & Wilkins; 1996.
2. Josling PD. A double blind placebo controlled evaluation of a garlic supplement in preventing the common cold. Altern Ther. 2001;18:July/August issue.
3. Data on file. Herbal Research Centre, East Sussex, United Kingdom.
4. Josling PD, Steadman S. Use of cellulose powder in the treatment of seasonal allergic rhinitis. Altern Nat Ther. 2003;20:July/August issue.
5. Emberlin JC, Lewis RA. A double blind, placebo controlled trial of inert cellulose powder for the relief of symptoms of hay fever in adults. Curr Med Res Opin. 2006;22:275-285.